PT1301207E - Composicoes para o tratamento de infeccoes bacterianas que contem um composto de oxazolidinona, sulbactam e ampicilina - Google Patents
Composicoes para o tratamento de infeccoes bacterianas que contem um composto de oxazolidinona, sulbactam e ampicilinaInfo
- Publication number
- PT1301207E PT1301207E PT01952176T PT01952176T PT1301207E PT 1301207 E PT1301207 E PT 1301207E PT 01952176 T PT01952176 T PT 01952176T PT 01952176 T PT01952176 T PT 01952176T PT 1301207 E PT1301207 E PT 1301207E
- Authority
- PT
- Portugal
- Prior art keywords
- sulbactam
- oxazolidinone
- ampicillin
- compositions
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21541800P | 2000-06-30 | 2000-06-30 | |
| US23277300P | 2000-09-15 | 2000-09-15 | |
| US27930601P | 2001-03-28 | 2001-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1301207E true PT1301207E (pt) | 2005-11-30 |
Family
ID=27396119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01952176T PT1301207E (pt) | 2000-06-30 | 2001-06-21 | Composicoes para o tratamento de infeccoes bacterianas que contem um composto de oxazolidinona, sulbactam e ampicilina |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6544991B2 (pt) |
| EP (1) | EP1301207B1 (pt) |
| JP (1) | JP2004501965A (pt) |
| AR (1) | AR029544A1 (pt) |
| AT (1) | ATE301474T1 (pt) |
| AU (1) | AU2001272961A1 (pt) |
| DE (1) | DE60112581T2 (pt) |
| DK (1) | DK1301207T3 (pt) |
| ES (1) | ES2245698T3 (pt) |
| MY (1) | MY128739A (pt) |
| PE (1) | PE20020295A1 (pt) |
| PT (1) | PT1301207E (pt) |
| TW (1) | TWI265030B (pt) |
| WO (1) | WO2002002095A2 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030096850A1 (en) * | 2001-10-11 | 2003-05-22 | Ford Charles W. | Treating infections by administration of oxazolidinones |
| WO2003084534A1 (en) * | 2002-03-29 | 2003-10-16 | Pharmacia & Upjohn Company Llc | Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
| AU2003224345A1 (en) * | 2002-04-30 | 2003-11-17 | Orchid Chemicals & Pharmaceuticals | Antibacterial agents |
| MX2007013895A (es) * | 2005-05-06 | 2008-01-28 | Wyeth Corp | Suministro de tigeciclina en la presencia de heparina. |
| JP2008544979A (ja) | 2005-06-29 | 2008-12-11 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 抗菌剤としてのホモモルホリンオキサゾリジノン |
| WO2007086014A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefpirome, tazobactam and linezolid |
| WO2007086011A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefepime, tazobactam and linezolid |
| WO2007086013A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising of ceftazidime, tazobactam and linezolid |
| WO2007086012A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation of cefpodoxime, clavulanic acid and linezolid |
| WO2008090570A1 (en) * | 2007-01-25 | 2008-07-31 | Panacea Biotec Ltd | Novel antimicrobials |
| JP5662940B2 (ja) | 2008-11-20 | 2015-02-04 | パナセア バイオテック リミテッド | 新規な抗微生物薬 |
| KR20120106697A (ko) | 2009-06-26 | 2012-09-26 | 파나세아 바이오테크 리미티드 | 신규 아자비시클로헥산 |
| WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2985648A (en) | 1958-10-06 | 1961-05-23 | Doyle Frank Peter | Alpha-aminobenzylpenicillins |
| GB902703A (en) | 1960-08-25 | 1962-08-09 | Beecham Res Lab | Penicillins |
| BE641785A (pt) | 1962-12-26 | |||
| US4234579A (en) | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
| SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
| US5968962A (en) | 1995-09-01 | 1999-10-19 | Pharmacia & Upjohn Company | Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings |
| DE19601264A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
| DE19601265A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
| DE19601627A1 (de) | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
| US5684024A (en) | 1996-01-25 | 1997-11-04 | Viropharma Incorporated | Pyrazole dimers compositions and methods for treating influenza |
| DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| KR100530297B1 (ko) | 1996-04-11 | 2005-11-22 | 파마시아 앤드 업존 캄파니 엘엘씨 | 옥사졸리디논의 제조 방법 |
| EP1028940B1 (en) | 1997-11-07 | 2007-04-18 | Pharmacia & Upjohn Company LLC | Process to produce oxazolidinones |
| DE60019630T2 (de) | 1999-02-01 | 2006-03-16 | Pharmacia & Upjohn Co. Llc, Kalamazoo | 2-Fluoro-(oxido-Thiopyran-4-yl)Benzol Derivate |
-
2001
- 2001-06-21 AU AU2001272961A patent/AU2001272961A1/en not_active Abandoned
- 2001-06-21 DK DK01952176T patent/DK1301207T3/da active
- 2001-06-21 WO PCT/US2001/019712 patent/WO2002002095A2/en active IP Right Grant
- 2001-06-21 US US09/886,641 patent/US6544991B2/en not_active Expired - Fee Related
- 2001-06-21 DE DE60112581T patent/DE60112581T2/de not_active Expired - Fee Related
- 2001-06-21 ES ES01952176T patent/ES2245698T3/es not_active Expired - Lifetime
- 2001-06-21 AT AT01952176T patent/ATE301474T1/de not_active IP Right Cessation
- 2001-06-21 JP JP2002506717A patent/JP2004501965A/ja active Pending
- 2001-06-21 EP EP01952176A patent/EP1301207B1/en not_active Expired - Lifetime
- 2001-06-21 PT PT01952176T patent/PT1301207E/pt unknown
- 2001-06-28 PE PE2001000643A patent/PE20020295A1/es not_active Application Discontinuation
- 2001-06-29 AR ARP010103125A patent/AR029544A1/es unknown
- 2001-06-29 TW TW090115958A patent/TWI265030B/zh not_active IP Right Cessation
- 2001-06-29 MY MYPI20013131A patent/MY128739A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004501965A (ja) | 2004-01-22 |
| EP1301207A2 (en) | 2003-04-16 |
| US6544991B2 (en) | 2003-04-08 |
| DE60112581T2 (de) | 2006-06-01 |
| EP1301207B1 (en) | 2005-08-10 |
| AU2001272961A1 (en) | 2002-01-14 |
| AR029544A1 (es) | 2003-07-02 |
| WO2002002095A2 (en) | 2002-01-10 |
| ATE301474T1 (de) | 2005-08-15 |
| MY128739A (en) | 2007-02-28 |
| TWI265030B (en) | 2006-11-01 |
| PE20020295A1 (es) | 2002-04-07 |
| DE60112581D1 (de) | 2005-09-15 |
| US20020022610A1 (en) | 2002-02-21 |
| WO2002002095A3 (en) | 2003-02-06 |
| WO2002002095B1 (en) | 2004-03-25 |
| DK1301207T3 (da) | 2005-10-10 |
| ES2245698T3 (es) | 2006-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1065789A1 (en) | Oxazolidinone and/or isoxazoline derivatives as antibacterial agents. | |
| IL168747A0 (en) | Oxazolidinone and/or isoxazoline derivatives as antibacterial agents | |
| ATE376996T1 (de) | Antibakterielle mittel | |
| NO20042271L (no) | Formuleringer som inneholder en cefalosporinforbindelse og deres anvendelse for behandling av bakterielle infeksjoner i katter og hunder | |
| PT1301207E (pt) | Composicoes para o tratamento de infeccoes bacterianas que contem um composto de oxazolidinona, sulbactam e ampicilina | |
| PT1313489E (pt) | Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet | |
| PT1424893E (pt) | Mistura fungicida que contem derivados de arilamidina. | |
| ECSP056229A (es) | Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres | |
| MA26866A1 (fr) | Agents antibacteriens consistant en 3-aminoquinazoline-2,4-diones | |
| EE200100594A (et) | Uudsed ravimikompositsioonid, mis põhinevad antikolinergiliselt toimivatel ühenditel ja ß-mimeetikumidel | |
| PT1193270E (pt) | Pirrolobenzodiazepinas | |
| GB0125222D0 (en) | Composition for the treatment of microbial infections | |
| CY1105224T1 (el) | Αντιμικροβιακες συνθεσεις ιστονης η1,κιτια, και μεθοδοι χρησιμοποιησεως αυτων | |
| EE200200620A (et) | IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud ateroskleroosi ravimiseks ja/või ennetamiseks | |
| AU2002232558A1 (en) | Compounds, compositions and methods for treatment of parasitic infections | |
| PT1560826E (pt) | Compostos piridopirimidinona, seus processos de preparacao e composicoes farmaceuticas que os contem | |
| EE200300064A (et) | Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine | |
| CL2004001421A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor. | |
| MXPA03006958A (es) | Composicion para administracion rectal de farmaco antibacterial de oxazolidinona. | |
| EE04811B1 (et) | Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim | |
| NZ509051A (en) | Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use | |
| NZ513603A (en) | ADP-ribosylation inhibitors and remedies for endotoxic bacterial enteric infection containing proanthocyanidin as the active ingredient | |
| SI1301207T1 (sl) | Sestavki za zdravljenje bakterijskih infekcij, ki vsebujejo oksazolidinonsko spojino, sulbaktam in ampicilin | |
| CL2004001343A1 (es) | Compuesto derivado del ester de 3,3-dimetil-4,4,7-trioxo-4-tia-1-aza-biciclo [3.2.0]-heptano-2-carboxilico, composicion farmaceutica, inhibidores de beta lactama, utiles para tratar una infeccion bacteriana. | |
| AU2003279979A1 (en) | Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |